Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1 Beta,3 Beta,5,11 Alpha,14,19- Hexahydroxy-5 Beta-card-20(22)-enolide
2. G-strophanthidin
1. G-strophanthidin
2. 508-52-1
3. Ouabain Genin
4. Chebi:71016
5. R2692w2t67
6. 3-[(1r,3s,5s,8r,9s,10r,11r,13r,14s,17r)-1,3,5,11,14-pentahydroxy-10-(hydroxymethyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2h-furan-5-one
7. 1beta,3beta,5,11alpha,14,19-hexahydroxy-5beta-card-20(22)-enolide
8. Nsc-97088
9. Unii-r2692w2t67
10. Nsc 97088
11. Brn 0060306
12. Ouabagenin, >=95%
13. Ouabagenin [mi]
14. 4-18-00-03554 (beilstein Handbook Reference)
15. Schembl643840
16. Chembl2068926
17. Dtxsid901026559
18. Card-20(22)-enolide, 1,3,5,11,14,19-hexahydroxy-, (1.beta.,3.beta.,5.beta.,11.alpha.)-
19. Zinc13475048
20. 1-beta,3-beta,5,11-alpha,14,19-hexahydroxy-5-beta-card-20(22)-enolide
21. Q1724241
22. 5beta-card-20(22)-enolide, 1beta,3beta,5,11alpha,14,19-hexahydroxy-
23. 1.beta.,3.beta.,5,11.alpha.,14,19-hexahydroxy-5.beta.-20(22)-cardenolide
24. 5-beta-card-20(22)-enolide, 1-beta,3-beta,5,11-alpha,14,19-hexahydroxy-
25. Card-20(22)-enolide, 1,3,5,11,14,19-hexahydroxy-, (1-beta,3-beta,5-beta,11-alpha)-
| Molecular Weight | 438.5 g/mol |
|---|---|
| Molecular Formula | C23H34O8 |
| XLogP3 | 0 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 2 |
| Exact Mass | 438.22536804 g/mol |
| Monoisotopic Mass | 438.22536804 g/mol |
| Topological Polar Surface Area | 148 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 813 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
10
PharmaCompass offers a list of Ouabagenin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ouabagenin manufacturer or Ouabagenin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ouabagenin manufacturer or Ouabagenin supplier.
PharmaCompass also assists you with knowing the Ouabagenin API Price utilized in the formulation of products. Ouabagenin API Price is not always fixed or binding as the Ouabagenin Price is obtained through a variety of data sources. The Ouabagenin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ouabagenin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ouabagenin, including repackagers and relabelers. The FDA regulates Ouabagenin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ouabagenin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ouabagenin supplier is an individual or a company that provides Ouabagenin active pharmaceutical ingredient (API) or Ouabagenin finished formulations upon request. The Ouabagenin suppliers may include Ouabagenin API manufacturers, exporters, distributors and traders.
Ouabagenin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ouabagenin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ouabagenin GMP manufacturer or Ouabagenin GMP API supplier for your needs.
A Ouabagenin CoA (Certificate of Analysis) is a formal document that attests to Ouabagenin's compliance with Ouabagenin specifications and serves as a tool for batch-level quality control.
Ouabagenin CoA mostly includes findings from lab analyses of a specific batch. For each Ouabagenin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ouabagenin may be tested according to a variety of international standards, such as European Pharmacopoeia (Ouabagenin EP), Ouabagenin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ouabagenin USP).
